OLDWICK, N.J., April 30, 2020 /PRNewswire/ -- Provention
Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical
company dedicated to intercepting and preventing immune-mediated
diseases, today announced that it will report its first quarter
2020 financial results on Thursday, May 7, 2020.
In connection with the earnings release, Provention's management
team will host a live conference call and webcast at 4:30 PM ET on Thursday, May 7, 2020, to
discuss the Company's financial results and provide a business
update.
Conference Call Information
To access the call, please
dial 1-877-870-4263 (domestic) or 1-412-317-0790 (international)
five minutes prior to the start time and ask to be connected to the
"Provention Bio Call." An audio webcast will also be available on
the "Events and Webcasts" page of the Investors section of the
Company's website, www.proventionbio.com. An archived webcast
will be available on the Company's website approximately two hours
after the conference call and will be available for seven days
following the call.
About Provention Bio, Inc.
Provention Bio, Inc.
(Nasdaq: PRVB) is a clinical-stage biopharmaceutical company
leveraging a transformational drug development strategy focused on
the prevention or interception of immune-mediated disease.
Provention's mission is to source, transform and develop
therapeutic candidates targeting the high morbidity, mortality and
escalating costs of autoimmune diseases. Provention's diversified
portfolio includes PRV-031 (teplizumab), a pre-commercial-stage
candidate that has been shown to delay the onset of end-stage type
one diabetes (T1D) in at-risk individuals with pre-symptomatic
disease. The Company's portfolio includes additional
clinical-stage product development candidates that have
demonstrated proof-of-mechanism and/or proof-of-concept
in other autoimmune diseases, including celiac disease and
lupus.
Investors:
Sam Martin,
Argot Partners
sam@argotpartners.com
212-600-1902
Media:
Lori Rosen, LDR Communications
lori@ldrcommunications.com
917-553-6808
View original content to download
multimedia:http://www.prnewswire.com/news-releases/provention-bio-to-report-first-quarter-2020-financial-results-and-host-conference-call-on-thursday-may-7-2020-301049974.html
SOURCE Provention Bio, Inc.